Prochlorperazine Edisylate Injection
Product Images NDC 55154-4183

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 55154-4183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 00

Label for Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL) multiple-dose vials. The label states the injection is for deep intramuscular or intravenous use only and is not for subcutaneous use. It includes storage instructions, dosage warnings, and manufacturer details, listing Cardinal Health 107, LLC as distributor and Emcure Pharmaceuticals Ltd. as manufacturer.*

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 01

A data table listing NDC 55154-4183-5 for Prochlorperazine Edisylate injection, showing it is supplied as 2 mL (10 mg) vials in bags of 5 vials, with the labeler Cardinal Health 107, LLC.*

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 02

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 03

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.